248 related articles for article (PubMed ID: 18713261)
1. Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation.
Panesar M; Banerjee S; Barone GW
Clin Transplant; 2008; 22(6):803-8. PubMed ID: 18713261
[TBL] [Abstract][Full Text] [Related]
2. Revisiting nephrogenic systemic fibrosis in 6 kidney transplant recipients: a single-center experience.
Lemy AA; del Marmol V; Kolivras A; High WA; Matos C; Laporte M; Nortier JL
J Am Acad Dermatol; 2010 Sep; 63(3):389-99. PubMed ID: 20619488
[TBL] [Abstract][Full Text] [Related]
3. Nephrogenic systemic fibrosis--a rapidly progressive disabling disease with limited therapeutic options.
Schieren G; Wirtz N; Altmeyer P; Rump LC; Weiner SM; Kreuter A
J Am Acad Dermatol; 2009 Nov; 61(5):868-74. PubMed ID: 19836645
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: three case reports and review of literature.
Mathur K; Morris S; Deighan C; Green R; Douglas KW
J Clin Apher; 2008; 23(4):144-50. PubMed ID: 18633995
[TBL] [Abstract][Full Text] [Related]
5. UV-A1 therapy for nephrogenic systemic fibrosis.
Tran KT; Prather HB; Cockerell CJ; Jacobe H
Arch Dermatol; 2009 Oct; 145(10):1170-4. PubMed ID: 19841406
[TBL] [Abstract][Full Text] [Related]
6. Nephrogenic systemic fibrosis in advanced chronic kidney disease: a single hospital's experience in Taiwan.
Chen W; Huang SL; Huang CS; Tsai MC; Lai HM; Lui CC; Eng HL; Chang HW; Lee CH; Chuang FR
Eur J Dermatol; 2009; 19(1):44-9. PubMed ID: 19059824
[TBL] [Abstract][Full Text] [Related]
7. Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposure.
Grobner T; Prischl FC
Semin Dial; 2008; 21(2):135-9. PubMed ID: 18226001
[TBL] [Abstract][Full Text] [Related]
8. Large sample of nephrogenic systemic fibrosis cases from a single institution.
Lee CU; Wood CM; Hesley GK; Leung N; Bridges MD; Lund JT; Lee PU; Pittelkow MR
Arch Dermatol; 2009 Oct; 145(10):1095-102. PubMed ID: 19841395
[TBL] [Abstract][Full Text] [Related]
9. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis in 2 patients with end-stage renal disease on hemodialysis.
Kim RH; Ma L; Hayat SQ; Ahmed MM
J Clin Rheumatol; 2006 Jun; 12(3):134-6. PubMed ID: 16755242
[TBL] [Abstract][Full Text] [Related]
10. The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report.
Wiedemeyer K; Kutzner H; Abraham JL; Thakral C; Carlson JA; Tran TA; Hausser I; Hartschuh W
Am J Dermatopathol; 2009 Oct; 31(7):674-81. PubMed ID: 19633532
[TBL] [Abstract][Full Text] [Related]
11. Gadolinium-associated nephrogenic systemic fibrosis in a 9-year-old boy.
Foss C; Smith JK; Ortiz L; Hanevold C; Davis L
Pediatr Dermatol; 2009; 26(5):579-82. PubMed ID: 19840315
[TBL] [Abstract][Full Text] [Related]
12. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
Kay J
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic systemic fibrosis associated with liver transplantation, renal failure and gadolinium.
Caccetta T; Chan JJ
Australas J Dermatol; 2008 Feb; 49(1):48-51. PubMed ID: 18186850
[TBL] [Abstract][Full Text] [Related]
14. Nephrogenic systemic fibrosis with a spectrum of clinical and histopathological presentation: a disorder of aberrant dermal remodeling.
Deng A; Martin DB; Spillane A; Chwalek J; St Surin-Lord S; Brooks S; Petrali J; Sina B; Gaspari A; Kao G
J Cutan Pathol; 2010 Feb; 37(2):204-10. PubMed ID: 19341434
[TBL] [Abstract][Full Text] [Related]
15. Nephrogenic systemic fibrosis: clinical picture and treatment.
Marckmann P; Skov L
Radiol Clin North Am; 2009 Sep; 47(5):833-40, vi. PubMed ID: 19744598
[TBL] [Abstract][Full Text] [Related]
16. Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin.
Jiménez SA; Artlett CM; Sandorfi N; Derk C; Latinis K; Sawaya H; Haddad R; Shanahan JC
Arthritis Rheum; 2004 Aug; 50(8):2660-6. PubMed ID: 15334482
[TBL] [Abstract][Full Text] [Related]
17. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
Hamilton-Persaud K; Ezell LD; Macklin JG
Nephrol Nurs J; 2007; 34(3):283-7; quiz 288. PubMed ID: 17644872
[TBL] [Abstract][Full Text] [Related]
18. Ten-year experience with nephrogenic systemic fibrosis: case-control analysis of risk factors.
Bahrami S; Raman SS; Sauk S; Salehmoghaddam S; Villablanca JP; Finn JP; Lu DS
J Comput Assist Tomogr; 2009; 33(6):819-23. PubMed ID: 19940643
[TBL] [Abstract][Full Text] [Related]
19. [Nephrogenic fibrosing dermopathy].
Engelen JW; Kooistra MP; Canninga-van Dijk MR; Toonstra J; Sigurdsson V
Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2435-8. PubMed ID: 14694555
[TBL] [Abstract][Full Text] [Related]
20. Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
Othersen JB; Maize JC; Woolson RF; Budisavljevic MN
Nephrol Dial Transplant; 2007 Nov; 22(11):3179-85. PubMed ID: 17890246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
